KANG [iKang Healthcare] DRS/A: (Original Filing)

[CONFIDENTIAL TREATMENT REQUESTED BY IKANG GUOBIN HEALTHCARE GROUP, INC. SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Guobin Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Guobin Healthcare Group, Inc. We are offering ADSs. Each ADS represents Class A common shares, par] [Equity Transfer Contract “Contract” This Equity Transfer Contract (the The Transferor: He Boquan ID No.: 440620196011075452 Address: No. 18, Lane 1, Yinglong Street, Xiaolan Town, Zhongshan City, Guangdong Province The Transferee: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai WHEREAS: “Guobin Healthcare Center” 1. Shanghai Guobin Healthcare Center Co., Ltd. ( 2. The Transferor] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Address: th 701, 7 Party B: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee th st Address: 701, 7 Party B: ID Number: 320102198102151619 Party C: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. the Party the Parties For the purpose of this Agreement, the Pledgee, Pledgors and Party C are individually referred to as “ Whereas:] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Party B: Party C: Party Parties In this Agreement, Party A, Party B and Party C are referred to as a “ WHEREAS: Party B, Hu Haiqing holds 80% of the equity interest in Party C on behalf of Party A; Party A regularly provides Party C] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Jiandatong Health Technology (Beijing) Co., Ltd., hereby irrevocably authorize ShanghaiMed iKang, Inc. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: ShanghaiMed iKang, Inc. is hereby authorized to act] [Statement and Acknowledgment I, as the shareholder of the 20% equity interest in Jiandatong Health Technology (Beijing) Co., Ltd. (hereinafter referred to as “Company”), hereby state and acknowledge that, in the event that Mr. Hu Haiqing transfers, in whole or in part, the 80% equity interest in the Company held by him to any third party, I agree to such] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated February 14, 2014 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc. its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012]

WUBA [58.com] SC 13G: (Original Filing)

[Joint Filing Agreement Jinbo Yao Jinbo Yao Xinyi Limited For and on behalf of Bakit Merah Limited as Corporate Director Credit Suisse Trust Limited as Trustee of The Xinyi Trust For and on behalf of Credit Suisse Trust Limited Nihao China Corporation EX-99.1 2 v368505_ex99-1.htm JOINT FILING AGREEMENT] []

EDU [New Oriental Education & Technology] SC 13G/A: (Original Filing)

[Joint Filing Agreement [Remainder of this page has intentionally been left blank.] Tigerstep Developments Limited Bamei Li Director Bamei Li Bamei Li EX-99.(A) 2 d676466dex99a.htm EX-99.(A)] [1 Names of reporting person Tigerstep Developments Limited (“Tigerstep”) 2 Check the appropriate box if a member of a group (see instructions) ¨ ¨ (a) 3 SEC use only 4 Citizenship or place of organization The British Virgin Islands Number of shares beneficially owned by each reporting person with: 5 Sole voting power 25,764,600 common shares. Tigerstep may be deemed]

By | 2016-03-26T22:55:23+00:00 February 14th, 2014|Categories: Chinese Stocks, EDU, SEC Original|Tags: , , , , , |0 Comments

VISN [VISIONCHINA MEDIA] SC 13G/A: (Original Filing)

[CUSIP No. 92833U103 13G/A 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Prescott Group Capital Management, L.L.C. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Oklahoma NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5]

By | 2016-03-21T04:44:02+00:00 February 14th, 2014|Categories: Chinese Stocks, SEC Original, VISN|Tags: , , , , , |0 Comments

QUNR [Qunar Cayman Islands] SC 13G: (Original Filing)

[Joint Filing Agreement 8 Baidu, Inc. Robin Yanhong Li Chairman and Chief Executive Officer Baidu Holdings Limited Robin Yanhong Li Director 9 EX-99.1 2 d676463dex991.htm EX-99.1] [1 NAMES OF REPORTING PERSONS Baidu, Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 185,202,519 Class A ordinary shares. Baidu Holdings Limited may also be deemed to]

MR [Mindray Medical International] SC 13G: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 5,946,754 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172% Item 12: HC Cusip #Y6035S107 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172%]

XUE [Xueda Education] SC 13G/A: (Original Filing)

[Joint Filing Agreement Remainder of this page has been left intentionally blank [ Rubin Li Rubin Li Goodor Corporation] [(1) This CUSIP number applies to the Issuer’s American Depositary Shares, each representing two Ordinary Shares. CUSIP No. 98418W109 Schedule 13G]

By | 2016-03-13T07:15:15+00:00 February 14th, 2014|Categories: Chinese Stocks, SEC Original, XUE|Tags: , , , , , |0 Comments

IDI [IDI] SC 13D/A: (Original Filing)

[SCHEDULE 13D/A CUSIP No. G88685105 Page 2 of 9 1. Names of reporting persons MOJICA LIMITED 2. Check the appropriate box if a member of a group (see instructions) x ¨ (a) 3. SEC use only 4. Source of funds (see instructions) OO 5. ¨ 6. Citizenship or place of organization]

By | 2016-03-13T17:30:47+00:00 February 14th, 2014|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] SC 13G/A: (Original Filing)

[CUSIP No. 88630M104 1. Names of reporting persons. I.R.S. Identification Nos. of above persons (entities only). 11-3694008 2. Check the appropriate box if a member of a group (see instructions) ¨ x (a) 3. SEC use only 4. Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: 5. Sole voting power 0 6.]

By | 2016-03-19T15:56:12+00:00 February 14th, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Skip to toolbar